Integrated network pharmacology and molecular dynamics-based computational evaluation of a novel Ganoderma lucidum-derived secondary metabolite as a multi-target therapeutic candidate against hepatocellular carcinoma
Introduction Hepatocellular carcinoma (HCC) is the predominant form of primary liver cancer and remains one of the leading causes of cancer-related mortality worldwide because of its increasing incidence, poor prognosis,…